ArticleBlood advances2021

The spleen as a sanctuary site for residual leukemic cells following ABT-199 monotherapy in ETP-ALL.

Alessandra Di Grande et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.